Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
01/2013
01/17/2013WO2013008700A1 Actinic ray-sensitive or radiation-sensitive resin composition, resist film and pattern forming method each using the composition, manufacturing method of electronic device and electronic device
01/17/2013WO2013007792A1 Novel th2 polarizing compounds
01/17/2013WO2013007582A2 Processes for the preparation of thietanamine
01/17/2013WO2013007106A1 Spiro compounds as hepatitis c virus inhibitors
01/17/2013WO2012146724A3 Novel rock inhibitors
01/17/2013US20130018189 2-phenyl-6-azolylpyridine-based ligand and group viii transition metal complex
01/17/2013US20130018073 Indole derivative
01/17/2013US20130018058 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
01/17/2013US20130017497 Synthesis and applications of soluble pentacene precursors and related compounds
01/17/2013CA2841095A1 Spiro compounds as hepatitis c virus inhibitors
01/16/2013EP2546252A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them
01/16/2013EP2546251A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them
01/16/2013EP2546250A1 Heteroaryl-substituted 1,3 dihydroindol-2-one derivatives and medicaments containing them
01/16/2013EP2546249A1 5-Alkynyl-pyridines
01/16/2013EP2546246A2 Compounds and methods for the treatment or prevention of flavivirus infections
01/16/2013EP2546239A1 6-amino isoquinolins compounds and methods for making the same
01/16/2013EP2546238A1 6-amino isoquinolins compounds and methods for making the same
01/16/2013EP2546237A1 7-amino isoquinolins compounds and methods for making the same
01/16/2013EP2545037A1 Inhibitors of protein kinases
01/16/2013EP2545036A1 Bis aromatic compounds for use as ltc4 synthase inhibitors
01/16/2013EP2544684A1 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1)
01/16/2013CN102884156A Light-emitting device material and light-emitting device
01/16/2013CN102884061A Method of making coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling
01/16/2013CN102884049A Heterocyclic amides as ROCK inhibitors
01/16/2013CN102875473A Preparation method of replaced-2-carbonyl imidazole compound
01/16/2013CN102875441A Plexxikon inc
01/16/2013CN102875273A Synthetic method of heteroaryl ether
01/16/2013CN101522669B Therapeutic lactams
01/15/2013CA2693997C Viral polymerase inhibitors
01/15/2013CA2567831C N-sulfonylcarboximidamide apoptosis promoters
01/15/2013CA2547391C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
01/10/2013WO2013006308A2 Dihydropyrazoles
01/10/2013WO2012101065A3 Pyrimidine biaryl amine compounds and their use as cdk9 inhibitors
01/10/2013WO2012061698A9 Compounds useful as modulators of trpm8
01/10/2013US20130012722 Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates
01/10/2013US20130012709 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
01/10/2013US20130012708 Heterocyclic compounds and thrombopoietin receptor activators
01/10/2013US20130012704 Compounds and compositions as protein kinase inhibitors
01/10/2013US20130012545 Amido-Thiophene Compounds and Their Use
01/10/2013US20130012543 Cytoskeletal active rho kinase inhibitor compounds, composition and use
01/10/2013US20130012540 Hepatitis C Virus Inhibitors
01/10/2013US20130012532 Cyclopropanecarboxylic acid derivative
01/10/2013US20130012504 Bi-functional quinoline analogs
01/10/2013US20130012503 Metalloenzyme inhibitor compounds
01/10/2013US20130012498 5ht2c receptor modulators
01/10/2013US20130012495 5ht2c receptor modulators
01/10/2013US20130012489 Morpholinylquinazolines
01/10/2013US20130012381 Pyridazine Compounds for Controlling Invertebrate Pests
01/10/2013US20130009543 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device
01/10/2013US20130009142 Charge transport compositions and electronic devices made with such compositions
01/10/2013CA2837524A1 Dihydropyrazoles
01/09/2013EP2543664A1 Compounds and methods for the treatment or prevention of flavivirus infections
01/09/2013EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase
01/09/2013EP2542538A1 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
01/09/2013EP2542528A1 Heterocyclic amides as rock inhibitors
01/09/2013EP2542086A1 Compounds and therapeutic uses thereof
01/09/2013CN102869729A Metal complex dye, photoelectric conversion element, and dye-sensitized solar cell
01/09/2013CN102869659A Bicarbazole containing compounds for OLEDs
01/09/2013CN102869657A Analogues for the treatment or prevention of flavivirus infections
01/09/2013CN102869656A Tetrahydrobenzothiophene compound
01/09/2013CN102863428A Spiro-compounds taken as hepatitis c virus (HCV) inhibitor
01/09/2013CN102863388A Tumor targeted drug Combretastatin A4 derivatives
01/09/2013CN102863387A Novel synthetic method for imidazole onium salts
01/09/2013CN102060753B Refining method of 4-phenylaminopiperidine analgesic
01/09/2013CN101573346B Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
01/09/2013CN101400655B Quinolone derivative or pharmaceutically acceptable salt thereof
01/09/2013CN101233127B Heterocyclic compound and organic electroluminescent device using same
01/08/2013US8350055 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
01/08/2013US8350041 Tricyclic δ-opioid modulators
01/08/2013US8349859 Pyrimidine derivatives
01/08/2013CA2642668C Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
01/08/2013CA2567574C Benzotriazine inhibitors of kinases
01/08/2013CA2557372C Diaminopyrimidines as p2x3 and p2x2/3 antagonists
01/08/2013CA2478731C Carbamates as hiv protease inhibitors
01/03/2013WO2013002357A1 Hiv replication inhibitor
01/03/2013WO2013002205A1 Nitrogen-containing heterocyclic compound and bactericide for agricultural or horticultural use
01/03/2013WO2013001997A1 Triphenyleno-benzofuran compound and organic light emitting element including the same
01/03/2013WO2013000994A1 Novel inhibitor compounds of phosphodiesterase type 10a
01/03/2013WO2012135027A3 Thiolactone antibiotics
01/03/2013US20130005993 Novel diaryl sulfone compound, and manufacturing method for same
01/03/2013US20130005985 Process Using Grignard Reagents
01/03/2013US20130005965 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
01/03/2013US20130005962 Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
01/03/2013US20130005767 Therapeutic compounds
01/03/2013US20130005729 Metalloenzyme inhibitor compounds
01/03/2013US20130005710 Aminopyridine derivative
01/03/2013US20130005675 Quinolone compound and pharmaceutical composition
01/03/2013US20130001540 Compound including indole derivative in which two tertiary amines are substituted, organic electronic element using same, and terminal thereof
01/03/2013US20130001524 Heterocyclic compound and organic light-emitting device comprising the same
01/03/2013CA2839655A1 Novel inhibitor compounds of phosphodiesterase type 10a
01/03/2013CA2838321A1 Sulphonamide derivatives of alicyclic amines for the treatment of the central nervous system diseases
01/02/2013EP2541635A1 Organic electroluminescent element
01/02/2013EP2540716A1 Tetrazolyloxime derivative or a salt thereof, and germicide
01/02/2013EP2539330A1 Dihydrofuran derivatives as insecticidal compounds
01/02/2013EP2539326A1 Bisaryl-bonded aryltriazolones and use thereof
01/02/2013EP2538941A1 Pyrrolidine substituted flavones for the treatment of inflammatory disorders
01/02/2013CN102858765A Pyrazolyl quinazoline kinase inhibitors
01/02/2013CN102858743A Spiro-condensed cyclohexane derivatives as HSL inhibitors useful for the treatment of diabetes
01/02/2013CN102851025A Intelligent rare-earth luminescent supramolecular device with photocontrollability and preparation thereof
01/02/2013CN102850336A Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 523